We have identified and validated five DEOSGs (NFKBIA, PLCE1, CLIC1, SLCO4A1, and TRAF3IP2) that can accurately predict the pathological outcome of AD patients. This evidence concerns the gene SLCO4A1 and Alzheimer disease.